Oral Excipients

Abstract Medication adherence remains a significant challenge in healthcare, particularly in paediatric populations, where non-adherence has a substantial impact on...

Abstract Objectives: The current study presents a sequential strategy for the development of directly compressible powder formulations relying on Design...

See our next webinar on the topic of: Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug...

Abstract Insufficient aqueous dissolution properties constitute a fundamental barrier impacting approximately 40% of commercialized and 90% developmental pharmaceuticals, significantly limiting...

Abstract Background/Objectives: Meloxicam (MLX) is a nonsteroidal anti-inflammatory drug (NSAID) recommended for treating acute and chronic pain in dogs, frequently...

Oral delivery, by Gattefossé, remains the most patient friendly route of administration. Yet for peptides, it has long been considered...

Proven effectiveness meets convincing properties and versatile applications: SOFTISAN® 378 has demonstrated its value for more than 30 years now....

Abstract Supersaturation is a widely employed strategy to improve the oral bioavailability of poorly soluble drugs, but its application is...

Abstract Here, we report dissolution of aprepitant from three phospholipid-based amorphous solid dispersions (ASDs), namely binary ASDs containing drug and...

Abstract Overcoming the gastrointestinal barrier to enable precise oral drug delivery to the small intestine and colorectum is crucial for...